361 related articles for article (PubMed ID: 25547651)
1. Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.
Teng E; Chow N; Hwang KS; Thompson PM; Gylys KH; Cole GM; Jack CR; Shaw LM; Trojanowski JQ; Soares HD; Weiner MW; Apostolova LG;
Dement Geriatr Cogn Disord; 2015; 39(3-4):154-66. PubMed ID: 25547651
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
Shen S; Zhou W; Chen X; Zhang J;
Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
[TBL] [Abstract][Full Text] [Related]
4. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
5. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
6. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
[TBL] [Abstract][Full Text] [Related]
7. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
9. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
11. The Role of MRI Biomarkers and Their Interactions with Cognitive Status and APOE ε4 in Nondemented Elderly Subjects.
Liang X; Yin Z; Liu R; Zhao H; Wu S; Lu J; Qing Z; Wei Y; Yang Q; Zhu B; Xu Y; Zhang B
Neurodegener Dis; 2018; 18(5-6):270-280. PubMed ID: 30673663
[TBL] [Abstract][Full Text] [Related]
12. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
13. Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI).
Ngwa JS; Fungwe TV; Ntekim O; Allard JS; Johnson SM; Castor C; Graham L; Nadarajah S; Gillum RF; Obisesan TO;
Dement Geriatr Cogn Disord; 2018; 45(1-2):66-78. PubMed ID: 29694964
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
15. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
Moreno-Grau S; Rodríguez-Gómez O; Sanabria Á; Pérez-Cordón A; Sánchez-Ruiz D; Abdelnour C; Valero S; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Lafuente A; Gil S; Santos-Santos MÁ; Alegret M; Espinosa A; Ortega G; Guitart M; Gailhajanet A; de Rojas I; Sotolongo-Grau Ó; Ruiz S; Aguilera N; Papasey J; Martín E; Peleja E; ; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MÁ; Giménez J; Serrano-Ríos M; Orellana A; Tárraga L; Ruiz A; Boada M;
Alzheimers Dement; 2018 May; 14(5):634-643. PubMed ID: 29156223
[TBL] [Abstract][Full Text] [Related]
16. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.
Schuff N; Woerner N; Boreta L; Kornfield T; Shaw LM; Trojanowski JQ; Thompson PM; Jack CR; Weiner MW;
Brain; 2009 Apr; 132(Pt 4):1067-77. PubMed ID: 19251758
[TBL] [Abstract][Full Text] [Related]
17. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.
Dhilla Albers A; Asafu-Adjei J; Delaney MK; Kelly KE; Gomez-Isla T; Blacker D; Johnson KA; Sperling RA; Hyman BT; Betensky RA; Hastings L; Albers MW
Ann Neurol; 2016 Dec; 80(6):846-857. PubMed ID: 27696605
[TBL] [Abstract][Full Text] [Related]
18. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
19. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M
Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824
[TBL] [Abstract][Full Text] [Related]
20. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
